Ishara Investments manages a private investment fund, Ishara Biotech Fund LP, and provides investment advisory services to sub-advisory accounts. Ishara's investment decisions are based on the client's investment objectives and guidelines. The firm focuses on data analysis to identify patterns in the biotechnology industry, primarily investing in US-listed small and mid-cap biotech companies.
Fee Structure
Ishara Investments manages investments for a private fund and sub-advisory accounts.
For the fund, investors pay an investment management fee of approximately 1.75% annually, calculated quarterly in advance. A Founders Class management fee is 1.25%.
For one sub-advisory account, Ishara receives a monthly expense reimbursement for research and operational expenses. For another sub-advisory account, Ishara is paid a management fee on a sliding scale, currently at 1.00%.